GlaxoSmithKline PLC carved off more of its non-core OTC brands with the sale of North American rights to five derma lines to Crown Laboratories Inc., which is carving out market share across skin care categories.
Crown Labs Spreads Out, GSK Narrows Focus In OTC Skin Care Brand Deal
GSK further narrows consumer health focus with sale to Crown Labs of North American distribution rights for PanOxyl acne wash, Sarna anti-itch lotion, Zeasorb anti-fungal product, Desenex athlete’s foot treatment and Mineral Ice pain-relieving gel. Deals also helps UK pharma pay for its $5.1bn acquisition of oncology drug firm Tesaro.
